Péter M. Szabó

4.2k total citations
52 papers, 1.9k citations indexed

About

Péter M. Szabó is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Péter M. Szabó has authored 52 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 19 papers in Molecular Biology and 18 papers in Surgery. Recurrent topics in Péter M. Szabó's work include Cancer Immunotherapy and Biomarkers (15 papers), MicroRNA in disease regulation (10 papers) and Adrenal and Paraganglionic Tumors (9 papers). Péter M. Szabó is often cited by papers focused on Cancer Immunotherapy and Biomarkers (15 papers), MicroRNA in disease regulation (10 papers) and Adrenal and Paraganglionic Tumors (9 papers). Péter M. Szabó collaborates with scholars based in United States, Hungary and Italy. Péter M. Szabó's co-authors include Péter Igaz, Attila Patócs, Kàroly Rácz, Padmanee Sharma, Zsófia Tömböl, Abdel Saci, Matthew D. Galsky, András Falus, Arlene O. Siefker‐Radtke and Henriett Butz and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Péter M. Szabó

51 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Péter M. Szabó United States 23 843 757 639 599 344 52 1.9k
Sang-Bae Kim United States 21 1.2k 1.4× 551 0.7× 339 0.5× 629 1.1× 498 1.4× 23 2.1k
Lui Ng Hong Kong 19 805 1.0× 651 0.9× 314 0.5× 676 1.1× 151 0.4× 45 1.6k
Vesselina G. Cooke United States 11 1.0k 1.2× 431 0.6× 213 0.3× 434 0.7× 611 1.8× 12 2.1k
Jason Kaplan United States 19 774 0.9× 399 0.5× 208 0.3× 612 1.0× 260 0.8× 61 1.7k
Armelle Logié United Kingdom 19 962 1.1× 433 0.6× 275 0.4× 442 0.7× 202 0.6× 33 1.6k
Brian Lu United States 19 510 0.6× 396 0.5× 322 0.5× 943 1.6× 342 1.0× 56 1.6k
Nobuo Ochi Japan 19 612 0.7× 283 0.4× 351 0.5× 695 1.2× 235 0.7× 41 1.4k
Kazuhiro Yoshida Japan 27 1.1k 1.4× 515 0.7× 325 0.5× 788 1.3× 362 1.1× 49 2.0k
David D. Chism United States 17 687 0.8× 232 0.3× 681 1.1× 554 0.9× 490 1.4× 30 1.7k

Countries citing papers authored by Péter M. Szabó

Since Specialization
Citations

This map shows the geographic impact of Péter M. Szabó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Péter M. Szabó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Péter M. Szabó more than expected).

Fields of papers citing papers by Péter M. Szabó

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Péter M. Szabó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Péter M. Szabó. The network helps show where Péter M. Szabó may publish in the future.

Co-authorship network of co-authors of Péter M. Szabó

This figure shows the co-authorship network connecting the top 25 collaborators of Péter M. Szabó. A scholar is included among the top collaborators of Péter M. Szabó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Péter M. Szabó. Péter M. Szabó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luke, Jason J., Katherine M. Bever, F. Stephen Hodi, et al.. (2025). Rationale and feasibility of a rapid integral biomarker program that informs immune-oncology clinical trials: the ADVISE trial. Journal for ImmunoTherapy of Cancer. 13(5). e011170–e011170. 2 indexed citations
2.
3.
Lei, Ming, Nathan O. Siemers, Dimple Pandya, et al.. (2021). Analyses of PD-L1 and Inflammatory Gene Expression Association with Efficacy of Nivolumab ± Ipilimumab in Gastric Cancer/Gastroesophageal Junction Cancer. Clinical Cancer Research. 27(14). 3926–3935. 57 indexed citations
4.
Ross‐Macdonald, Petra, Alice M. Walsh, Scott D. Chasalow, et al.. (2021). Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC. Journal for ImmunoTherapy of Cancer. 9(3). e001506–e001506. 28 indexed citations
5.
Szabó, István, et al.. (2021). In Situ Investigation of Plastic-Associated Bacterial Communities in a Freshwater Lake of Hungary. Water Air & Soil Pollution. 232(12). 23 indexed citations
6.
Galsky, Matthew D., Abdel Saci, Péter M. Szabó, et al.. (2020). Nivolumab in Patients with Advanced Platinum-resistant Urothelial Carcinoma: Efficacy, Safety, and Biomarker Analyses with Extended Follow-up from CheckMate 275. Clinical Cancer Research. 26(19). 5120–5128. 83 indexed citations
7.
Goswami, Sangeeta, Yulong Chen, Swetha Anandhan, et al.. (2020). ARID1A mutation plus CXCL13 expression act as combinatorial biomarkers to predict responses to immune checkpoint therapy in mUCC. Science Translational Medicine. 12(548). 92 indexed citations
8.
Wang, Li, Yixuan Gong, Abdel Saci, et al.. (2019). Fibroblast Growth Factor Receptor 3 Alterations and Response to PD-1/PD-L1 Blockade in Patients with Metastatic Urothelial Cancer. European Urology. 76(5). 599–603. 89 indexed citations
9.
Wang, Li, Abdel Saci, Péter M. Szabó, et al.. (2018). EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer. Nature Communications. 9(1). 3503–3503. 216 indexed citations
10.
Módos, Dezső, Krishna C. Bulusu, Dávid Fazekas, et al.. (2017). Neighbours of cancer-related proteins have key influence on pathogenesis and could increase the drug target space for anticancer therapies. npj Systems Biology and Applications. 3(1). 2–2. 20 indexed citations
11.
Szabó, Péter M., Kinga Németh, Katalin Szabó, et al.. (2017). Limitations of high throughput methods for miRNA expression profiles in non-functioning pituitary adenomas. Pathology & Oncology Research. 25(1). 169–182. 12 indexed citations
12.
Galsky, Matthew D., Abdel Saci, Péter M. Szabó, et al.. (2017). Impact of zumor mutation burden on nivolumab efficacy in second-line urothelial carcinoma patients: Exploratory analysis of the phase ii checkmate 275 study. Annals of Oncology. 28. v296–v297. 49 indexed citations
13.
Nagy, Zsolt, Henriett Butz, Péter M. Szabó, et al.. (2015). Overexpression of GRß in colonic mucosal cell line partly reflects altered gene expression in colonic mucosa of patients with inflammatory bowel disease. The Journal of Steroid Biochemistry and Molecular Biology. 155(Pt A). 76–84. 9 indexed citations
14.
Igaz, Péter, Zsolt Nagy, Gábor Nyírő, et al.. (2014). MicroRNAs in adrenal tumors: relevance for pathogenesis, diagnosis, and therapy. Cellular and Molecular Life Sciences. 72(3). 417–428. 44 indexed citations
15.
Luconi, Michaela, Péter M. Szabó, Miklós Tóth, et al.. (2013). Analysis of circulating microRNAs in adrenocortical tumors. Laboratory Investigation. 94(3). 331–339. 85 indexed citations
16.
Szabó, Péter M., K. Rácz, & Péter Igaz. (2011). Underexpression of C-myc in Adrenocortical Cancer: A Major Pathogenic Event?. Hormone and Metabolic Research. 43(5). 297–299. 13 indexed citations
17.
Tamas, Laszlo B., Gábor Répássy, Péter M. Szabó, et al.. (2011). Spontaneous Remission in Localized Diffuse Large B-cell Lymphoma. Pathology & Oncology Research. 17(3). 779–784. 15 indexed citations
18.
Tömböl, Zsófia, Katalin Éder, Attila Kovács, et al.. (2010). MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas. Modern Pathology. 23(12). 1583–1595. 51 indexed citations
19.
Tömböl, Zsófia, Péter M. Szabó, Viktor Molnár, et al.. (2009). Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis. Endocrine Related Cancer. 16(3). 895–906. 146 indexed citations
20.
Igaz, Péter, Zsófia Tömböl, Péter M. Szabó, István Likó, & K. Rácz. (2008). Steroid Biosynthesis Inhibitors in the Therapy of Hypercortisolism: Theory and Practice. Current Medicinal Chemistry. 15(26). 2734–2747. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sang-Bae Kim Breakdown of academic impact, for papers by Lui Ng Breakdown of academic impact, for papers by Vesselina G. Cooke Breakdown of academic impact, for papers by Jason Kaplan Breakdown of academic impact, for papers by Armelle Logié Breakdown of academic impact, for papers by Brian Lu Breakdown of academic impact, for papers by Nobuo Ochi Breakdown of academic impact, for papers by Kazuhiro Yoshida Breakdown of academic impact, for papers by David D. Chism
Rankless by CCL
2026